- Home
- PLTK vs PTGX Comparison
PLTK vs PTGX Comparison
Compare PLTK & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- PTGX
- Stock Information
- Founded
- PLTK 2010
- PTGX 2006
- Country
- PLTK Israel
- PTGX United States
- Employees
- PLTK N/A
- PTGX N/A
- Industry
- PLTK EDP Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- PLTK Technology
- PTGX Health Care
- Exchange
- PLTK Nasdaq
- PTGX Nasdaq
- Market Cap
- PLTK 2.6B
- PTGX 2.7B
- IPO Year
- PLTK 2021
- PTGX 2016
- Fundamental
- Price
- PLTK $7.00
- PTGX $36.82
- Analyst Decision
- PLTK Hold
- PTGX Strong Buy
- Analyst Count
- PLTK 10
- PTGX 8
- Target Price
- PLTK $8.80
- PTGX $54.63
- AVG Volume (30 Days)
- PLTK 937.1K
- PTGX 660.4K
- Earning Date
- PLTK 02-24-2025
- PTGX 02-25-2025
- Dividend Yield
- PLTK 5.71%
- PTGX N/A
- EPS Growth
- PLTK N/A
- PTGX N/A
- EPS
- PLTK 0.58
- PTGX 2.68
- Revenue
- PLTK $2,536,900,000.00
- PTGX $323,795,000.00
- Revenue This Year
- PLTK N/A
- PTGX $441.08
- Revenue Next Year
- PLTK $4.29
- PTGX N/A
- P/E Ratio
- PLTK $12.05
- PTGX $13.72
- Revenue Growth
- PLTK N/A
- PTGX 125.73
- 52 Week Low
- PLTK $6.25
- PTGX $23.89
- 52 Week High
- PLTK $9.16
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- PLTK 41.89
- PTGX 39.62
- Support Level
- PLTK $6.64
- PTGX $35.03
- Resistance Level
- PLTK $7.03
- PTGX $40.07
- Average True Range (ATR)
- PLTK 0.21
- PTGX 1.56
- MACD
- PLTK 0.05
- PTGX -0.04
- Stochastic Oscillator
- PLTK 66.97
- PTGX 34.89
About PLTK Playtika Holding Corp.
Playtika Holding Corp is primarily engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It primarily derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.